Cablivi gets FDA OK for blood clotting disorder

7th February 2019 Uncategorised 0

The US Food and Drug Administration (FDA) has approved Sanofi’s Cablivi as the first treatment for adult patients with a rare blood clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP).

More: Cablivi gets FDA OK for blood clotting disorder
Source: News